Rosa Conforti

2.1k total citations
29 papers, 757 citations indexed

About

Rosa Conforti is a scholar working on Oncology, Cancer Research and Immunology. According to data from OpenAlex, Rosa Conforti has authored 29 papers receiving a total of 757 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 9 papers in Cancer Research and 8 papers in Immunology. Recurrent topics in Rosa Conforti's work include Cancer Treatment and Pharmacology (5 papers), HER2/EGFR in Cancer Research (5 papers) and Breast Cancer Treatment Studies (4 papers). Rosa Conforti is often cited by papers focused on Cancer Treatment and Pharmacology (5 papers), HER2/EGFR in Cancer Research (5 papers) and Breast Cancer Treatment Studies (4 papers). Rosa Conforti collaborates with scholars based in France, Italy and United States. Rosa Conforti's co-authors include Laurence Zitvogel, Fabrice André, Guido Kroemer, Yuting Ma, Nathalie Chaput, Sophie Viaud, Yannis Morel, Suzette Delaloge, Gorana Tomasic and Clara Locher and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Rosa Conforti

27 papers receiving 748 citations

Peers

Countries citing papers authored by Rosa Conforti

Since Specialization

Citations

This map shows the geographic impact of Rosa Conforti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosa Conforti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosa Conforti more than expected).

Fields of papers citing papers by Rosa Conforti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosa Conforti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosa Conforti. The network helps show where Rosa Conforti may publish in the future.

Co-authorship network of co-authors of Rosa Conforti

This figure shows the co-authorship network connecting the top 25 collaborators of Rosa Conforti. A scholar is included among the top collaborators of Rosa Conforti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosa Conforti. Rosa Conforti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinical and radiological pattern of olaparib-induced interstitial lung disease 2024 ·BMC Pulmonary Medicine ·(unknown), (unknown), Frédèric Selle, Emmanuel Seront, Rosa Conforti, G. Veyrac, Aurore Gouraud, Bénédicte Lebrun‐Vignes, Antoine Khalil, Gérard Zalcman, V. Gounant	0
2	Mise à jour concernant la prise en charge du cancer de la vulve : les recommandations de l’Assistance publique–hôpitaux de Paris 2019 ·Bulletin du Cancer ·Henri Azaïs, (unknown), J. Belghiti, (unknown), C. Gonthier, P. Maingon, Rosa Conforti, Catherine Uzan, Geoffroy Canlorbe	3
3	Métastases cérébrales de cancer du sein : traitements systémiques 2015 ·Cancer/Radiothérapie ·Sophie Taillibert, Rosa Conforti, Jacques Bonneterre, Thomas Bachelot, Émilie Le Rhun, Chantal Bernard-Marty	6
4	Association between the nuclear to cytoplasmic ratio of p27 and the efficacy of adjuvant polychemotherapy in early breast cancer 2012 ·Annals of Oncology ·Fabrice André, Rosa Conforti, C. Moeder, Audrey Mauguen, Mónica Arnedos, (unknown), Suzette Delaloge, Gorana Tomasic, M. Spielmann, Francisco J. Esteva, David L. Rimm, Stefan Michiels	10
5	TLR3 as a Biomarker for the Therapeutic Efficacy of Double-stranded RNA in Breast Cancer 2011 ·Cancer Research ·Bruno Salaun, Laurence Zitvogel, Carine Asselin‐Paturel, Yannis Morel, Karine Chemin, (unknown), Catherine Massacrier, Rosa Conforti, Marie Pierre Chenard, Jean‐Christophe Sabourin, Aïcha Goubar, Serge Lebecque, Michel Pierres, Donata Rimoldi, Pedro Romero, Fabrice André	93
6	An inhibitor of cyclin-dependent kinases suppresses TLR signaling and increases the susceptibility of cancer patients to herpes viridae 2011 ·Cell Cycle ·Mustapha Zoubir, Caroline Flament, Abdelaziz Gdoura, Rastilav Bahleda, Е. Г. Литвинова, Vassili Soumelis, Rosa Conforti, Sophie Viaud, Jean‐Charles Soria, Guido Kroemer, Laurence Zitvogel, Nathalie Chaput	7
7	How to improve the immunogenicity of chemotherapy and radiotherapy 2011 ·Cancer and Metastasis Reviews ·Yuting Ma, Rosa Conforti, Laetitia Aymeric, Clara Locher, Oliver Kepp, Guido Kroemer, Laurence Zitvogel	66
8	Opposing Effects of Toll-like Receptor (TLR3) Signaling in Tumors Can Be Therapeutically Uncoupled to Optimize the Anticancer Efficacy of TLR3 Ligands 2010 ·Cancer Research ·Rosa Conforti, Yuting Ma, Yannis Morel, Carine Paturel, Magali Terme, Sophie Viaud, Bernard Ryffel, Maria Ferrantini, Ravindra Uppaluri, Robert D. Schreiber, Christophe Combadière, Nathalie Chaput, Fabrice André, Guido Kroemer, Laurence Zitvogel	87
9	Mécanismes de résistance aux thérapeutiques moléculaires ciblées dans le cancer du sein : constats et perspectives 2010 ·Bulletin du Cancer ·Nicolas Magné, Cyrus Chargari, Rosa Conforti, Robert‐Alain Toillon, (unknown), Lionel Védrine, D. Khayat, Jean-Philippe Spano	1
10	Desirable cell death during anticancer chemotherapy 2010 ·Annals of the New York Academy of Sciences ·Clara Locher, Rosa Conforti, Laetitia Aymeric, Yuting Ma, Takahiro Yamazaki, Sylvie Rusakiewicz, Antoine Tesnière, François Ghiringhelli, Lionel Apétoh, Yannis Morel, Jean‐Philippe Girard, Guido Kroemer, Laurence Zitvogel	62
11	Prévalence de l'élévation du CA 15-3 lors de la rechute métastatique des cancers du sein: corrélation avec l'expression des récepteurs hormonaux et de Her2 2009 ·Bulletin du Cancer ·Y. Bensouda, Fabrice André, Thomas Boulet, (unknown), Rosa Conforti, Frédéric Troalen, C. Bourgier, Hassan Errihani, M. Spielmann, (unknown)	10
12	CXCR4 Expression in Early Breast Cancer and Risk of Distant Recurrence 2009 ·The Oncologist ·Fabrice André, Weiya Xia, Rosa Conforti, Yongkun Wei, Thomas Boulet, Gorana Tomasic, M. Spielmann, (unknown), (unknown), R. Arriagada, Gabriel N. Hortobágyi, Mien‐Chie Hung, Lajos Pusztai, Suzette Delaloge, Stefan Michiels, Massimo Cristofanilli	55
13	Quantification of circulating mature endothelial cells using a whole blood four-color flow cytometric assay 2008 ·Journal of Immunological Methods ·Nathalie Jacques, Nadège Vimond, Rosa Conforti, Frank Griscelli, Yann Lécluse, Agnès Laplanche, David Malka, Philippe Vielh, Françoise Farace	40
14	The Janus face of dendritic cells in cancer 2008 ·Oncogene ·Nathalie Chaput, Rosa Conforti, Sophie Viaud, Alan Spatz, Laurence Zitvogel	67
15	Breast cancer molecular subclassification and estrogen receptor expression to predict efficacy of adjuvant anthracyclines-based chemotherapy: a biomarker study from two randomized trials 2007 ·Annals of Oncology ·Rosa Conforti, Thomas Boulet, Gorana Tomasic, E. Taranchon, R. Arriagada, M. Spielmann, (unknown), J.C. Soria, Thomas Tursz, Suzette Delaloge, Stefan Michiels, Fabrice André	69
16	Expression patterns and predictive value of phosphorylated AKT in early-stage breast cancer 2007 ·Annals of Oncology ·Fabrice André, Rita Nahta, Rosa Conforti, Thomas Boulet, (unknown), Linda X.H. Yuan, Franck Meslin, M. Spielmann, Gorana Tomasic, L. Pusztai, Gabriel N. Hortobágyi, Stefan Michiels, Suzette Delaloge, Francisco J. Esteva	32
17	Efficacy of adjuvant chemotherapy according to Prion protein expression in patients with estrogen receptor-negative breast cancer 2007 ·Annals of Oncology ·Franck Meslin, Rosa Conforti, Chafika Mazouni, N. Costedoat‐Chalumeau, Gorana Tomasic, Françoise Drusch, (unknown), Jean‐Christophe Sabourin, Jacques Grassi, Suzette Delaloge, (unknown), Salem Chouaı̈b, Fabrice André, Maryam Mehrpour	36
18	Carboplatin and etoposide (CE) chemotherapy in patients with recurrent or progressive oligodendroglial tumors 2006 ·Journal of Neuro-Oncology ·L. Scopece, Enrico Franceschi, Giovanna Cavallo, Anna Paioli, (unknown), Rosa Conforti, Emanuela Palmerini, (unknown), F. Spagnolli, (unknown), Lucio Crinò	8
19	Phase II trial of carboplatin and etoposide for patients with recurrent high-grade glioma 2004 ·British Journal of Cancer ·Enrico Franceschi, Giovanni Cavallo, L. Scopece, Anna Paioli, Andrea Pession, Elisabetta Magrini, Rosa Conforti, Emanuela Palmerini, Stefania Bartolini, S Rimondini, (unknown), Lucio Crinò	41
20	Real-Time RT-PCR of tyrosine hydroxylase to detect bone marrow involvement in advanced neuroblastoma 2003 ·Oncology Reports ·Andrea Pession, (unknown), (unknown), Rosa Conforti, Elisabetta Magrini, Livia Bernardi, Raffaele Fronza, Eleonora Olivotto, Arcangelo Prete, Roberto Tonelli, G Paolucci	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact